FDA Clearance Tracker · K193650
LIAISON Ferritin
Last checked: Nov 20, 2026Latest source record: Sep 14, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Sep 14, 2021
Substantially Equivalent
Time to decision
624 days
Received Dec 30, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K193650
- Device name
- LIAISON Ferritin
- Applicant
- DiaSorin, Inc.
- Applicant location
- Stillwater, MN
- Received
- Dec 30, 2019
- Decided
- Sep 14, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Ferritin, Antigen, Antiserum, Control (DBF)
- Device class
- Class II
- Regulation
- 21 CFR 866.5340
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DBF. The earliest in FDA's data is K770702, decided Jun 17, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K193650
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for DiaSorin, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260770 · Decided Jun 4, 2026 · 87 days after receipt
Device type: Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) (LOM) · Laboratory Medicine & Pathology
P250039 · Decided May 7, 2026 · 220 days after receipt
Device type: ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGM (MYM) · Laboratory Medicine & Pathology
- LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)New device typeBreakthroughDe Novo
DEN250032 · Decided Dec 23, 2025 · 146 days after receipt
Device type: Device To Detect Antibodies To Hepatitis D Virus (SGW) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.